Study guide
Infectious, chlamydial and neonatal conjunctivitis
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Infectious, chlamydial and neonatal conjunctivitis
Key Takeaways Explain This Topic AI
Follicles, discharge, membranes and exposure history guide conjunctivitis assessment, while corneal involvement changes urgency.
Hyperacute gonococcal disease requires systemic treatment and assessment for associated infection.
Neonatal chlamydial disease needs systemic treatment and monitoring; topical drops alone do not address respiratory infection.
Last updated: October 2026
The conjunctiva is a continuous, vascularised mucous membrane lining the posterior surface of the eyelids (palpebral conjunctiva), reflecting across the superior and inferior fornices, and draping over the anterior sclera up to the corneal limbus (bulbar conjunctiva). The substantia propria contains an extensive mucosa-associated lymphoid tissue (MALT) network with resident lymphocytes, plasma cells, mast cells, and dendritic Langerhans cells. Conjunctival inflammation (conjunctivitis) exhibits distinct biomicroscopic patterns—follicles, papillae, membranes, and cicatrisation—that correlate with underlying infectious, allergic, or autoimmune etiologies.
- 1. Acute Infectious Conjunctivitis: Microbial Etiologies
- Acute Bacterial Conjunctivitis
Most common in children and elderly patients, classic acute bacterial conjunctivitis presents with acute-onset redness, grittiness, morning eyelid sticking (mattering), and mucopurulent discharge. Common culprits include Streptococcus pneumoniae , Haemophilus influenzae (frequently associated with concurrent otitis media in young children), Staphylococcus aureus , and Moraxella catarrhalis . Biomicroscopy reveals a tarsal papillary reaction (vascular core surrounded by inflammatory cells). While typically self-limiting within 7 to 10 days, broad-spectrum topical antibiotics (chloramphenicol 0.5%, polymyxin B/trimethoprim, or fluoroquinolones) accelerate clinical and microbiological clearance.
Hyperacute Purulent Conjunctivitis ( Neisseria gonorrhoeae )
Neisseria gonorrhoeae is a fastidious, sexually transmitted Gram-negative diplococcus capable of penetrating an intact corneal epithelium . It constitutes a medical and ophthalmic emergency.
Clinical Presentation : Rapid progression within 12 to 24 hours characterised by copious, thick, torrential purulent exudate that overflows the lid margins and re-accumulates within seconds of wiping. Profound chemosis, marked eyelid oedema, and a tender, prominent preauricular lymph node may occur; their absence does not exclude infection.
Corneal Risk : Rapid stromal invasion and enzymatic degradation by bacterial proteases can lead to stromal liquefaction, descemetocele formation, and corneal perforation within 24 to 48 hours .
Diagnostics : Immediate conjunctival swab for Gram stain demonstrating intracellular Gram-negative diplococci within polymorphonuclear leukocytes; culture on Thayer-Martin chocolate agar incubated in 5 % CO 2 5\%\text{ CO}_2 5% CO 2 ; and nucleic acid amplification testing (NAAT).
Emergency Treatment : Systemic therapy is mandatory:
CDC recommends ceftriaxone 1 g intramuscularly once for adolescent/adult gonococcal conjunctivitis; consider one-time saline lavage and infectious-disease advice.
If chlamydia has not been excluded, add the appropriate antichlamydial treatment; the usual non-pregnant adult regimen is doxycycline 100 mg twice daily for seven days. Routine ceftriaxone–azithromycin dual therapy is outdated.
Corneal ulceration or disseminated infection needs urgent specialist assessment and a treatment plan for that complication, not automatic extension of a simple-conjunctivitis regimen.
Viral Conjunctivitis: Adenoviral Syndromes
Adenovirus is a non-enveloped double-stranded DNA virus responsible for the vast majority of viral ocular infections. Adenoviral conjunctivitis manifests primarily as two clinical syndromes:
Pharyngoconjunctival Fever (PCF) : Caused primarily by serotypes 3, 4, and 7; characterized by high fever, pharyngitis, tender preauricular lymphadenopathy, and bilateral follicular conjunctivitis, most commonly in school-aged children.
Epidemic Keratoconjunctivitis (EKC) : Caused primarily by serotypes 8, 19, 37, 54, and 64; an aggressive, purely ocular infection with high epidemic transmissibility.
Slit-Lamp Biomicroscopy of Adenoviral Conjunctivitis
Follicular Response : Elevated, translucent, avascular lymphoid germinal centres surrounded by fine peripheral vessels, prominent in the inferior palpebral conjunctiva.
Petechial Subconjunctival Haemorrhages : Common in severe serotype infections.
Pseudomembranes vs True Membranes : Coagulated fibrinous exudate adhering to the inflamed conjunctival epithelium. Pseudomembranes can be peeled away leaving an intact epithelium without bleeding. True membranes incorporate the superficial epithelial layers; peeling leaves a raw, actively bleeding bed that predisposes to conjunctival cicatrisation and symblepharon if not removed.
Nummular Subepithelial Corneal Infiltrates (SEIs) : Appear 1 to 3 weeks after the onset of conjunctivitis as round, discrete, grey-white anterior stromal opacities underlying previous focal epithelial lesions. SEIs represent an immune-mediated delayed hypersensitivity reaction to viral capsid antigens retained within the stroma. They induce glare, photophobia, and reduced visual acuity.
Tip
SEIs respond rapidly to low-potency topical corticosteroids (loteprednol etabonate 0.5% or fluorometholone 0.1%), but premature steroid cessation frequently triggers severe recurrence. Topical Ciclosporin 0.05%–1% drops provide an excellent, non-cataractogenic steroid-sparing maintenance therapy that suppresses SEIs without elevating intraocular pressure.
- 2. Chlamydial Conjunctivitis & Ophthalmia Neonatorum
- Adult Inclusion Conjunctivitis ( Chlamydia trachomatis Serovars D–K)
An oculogenital infection transmitted by autoinoculation from infected genital secretions in sexually active adolescents and young adults:
Clinical Manifestations : Subacute or chronic follicular conjunctivitis persisting for weeks or months. Biomicroscopy reveals large, prominent follicles in the inferior fornix , mixed with a fine papillary reaction, superficial micropannus, peripheral subepithelial corneal infiltrates, and non-tender preauricular adenopathy.
Diagnostics : Conjunctival NAAT swab (gold standard) or Giemsa staining demonstrating basophilic intracytoplasmic Halberstaedter-Prowazek inclusion bodies .
Therapy : Systemic treatment is essential to eradicate the genital reservoir: Oral Azithromycin 1 g single dose or Oral Doxycycline 100 mg twice daily for 7 to 14 days . Sexual partners must be evaluated and treated concurrently.
Trachoma ( Chlamydia trachomatis Serovars A, B, Ba, C)
The leading infectious cause of preventable blindness worldwide. The World Health Organization (WHO) simplified grading system defines:
TF (Trachomatous inflammation - Follicular) : ≥ 5 \ge 5 ≥ 5 follicles ( ≥ 0.5 mm \ge 0.5\text{ mm} ≥ 0.5 mm ) on the upper tarsal conjunctiva.
TI (Trachomatous inflammation - Intense) : Pronounced inflammatory thickening of the tarsal conjunctiva obscuring > 50 % > 50\% > 50% of deep normal tarsal vessels.
TS (Trachomatous conjunctival Scarring) : Presence of linear or stellate cicatricial bands ( Arlt's line across the superior tarsus).
TT (Trachomatous Trichiasis) : At least one lash rubbing against the eyeball.
CO (Corneal Opacity) : Corneal scarring over the pupil.
characteristic sign: Herbert's pits —depressed, circular cicatricial depressions at the superior limbus representing resolved limbal follicles. Managed by the WHO SAFE strategy : S urgery for trichiasis, A ntibiotics (mass azithromycin distribution), F acial cleanliness, E nvironmental improvement.
Ophthalmia Neonatorum Chronological Differential
Ophthalmia neonatorum is defined as any conjunctivitis occurring within the first 28 days of neonatal life. The clinical timeline is essential for board examinations:
Onset Post-Partum Primary Etiology Clinical Features & Gram Stain Definitive Treatment
< 24 Hours Chemical (Silver nitrate / Credé prophylaxis) Mild conjunctival hyperaemia, sterile watery discharge; self-limiting Observation; preservative-free lubricants
Days 2–5 Neisseria gonorrhoeae Hyperacute, severe chemosis, torrential purulent discharge; Gram-negative intracellular diplococci; risk of rapid corneal perforation IV/IM Ceftriaxone 25–50 mg/kg (maximum 250 mg) single dose + intensive saline irrigation
Days 5–14 Chlamydia trachomatis (Most common infectious cause) Mucopurulent discharge, tarsal papillary hypertrophy (neonates lack mature lymphoid tissue to form follicles); risk of chlamydial pneumonitis Oral Erythromycin 50 mg/kg/day divided in 4 doses for 14 days (or oral azithromycin)
Days 5–14+ Herpes Simplex Virus (HSV-2) Serosanguinous discharge, vesicular eyelid skin lesions, microdendrites; risk of systemic disseminated neonatal herpes Intravenous Aciclovir 60 mg/kg/day in 3 divided doses for 14–21 days
Neonatal gonococcal disease needs assessment for disseminated infection and chlamydia. Ceftriaxone requires caution in hyperbilirubinaemic or premature infants and is unsuitable with simultaneous intravenous calcium; CDC provides a cefotaxime alternative in that setting. Chlamydial disease requires systemic treatment and follow-up because topical therapy alone does not address associated respiratory infection. Monitor neonatal macrolide exposure for pyloric stenosis. CDC neonatal gonococcal guidance .